Summary & Overview
HCPCS C9795: Stereotactic Body Radiation Therapy Delivery with PET-Based Adjustments
HCPCS Level II code C9795 represents stereotactic body radiation therapy (SBRT) treatment delivery, billed per fraction for one or more lesions, and includes image guidance with real-time positron emissions-based delivery adjustments. It is limited to an entire course not to exceed five fractions. This code captures advanced radiation-delivery techniques that integrate imaging and PET-based real-time targeting adjustments, reflecting a growing emphasis on precision dose delivery in radiation oncology.
Key payers in this national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations and payer approaches, along with clinical context for when the code is used. The publication summarizes benchmarks for utilization and reimbursement where available, highlights recent policy updates affecting SBRT delivery codes, and outlines operational details relevant to billing and documentation.
The content provides clinical context for SBRT delivery per fraction, outlines typical sites of service, and identifies common billing modifiers and related administrative considerations. Data not available in the input is noted where applicable. This summary is intended for health policy analysts, revenue cycle professionals, and clinical leaders seeking a national-level briefing on the role and billing characteristics of C9795 in modern radiation oncology practice.
Billing Code Overview
HCPCS Level II code C9795 describes stereotactic body radiation therapy (SBRT) treatment delivery billed per fraction for one or more lesions. The code includes image guidance and real-time positron emissions-based delivery adjustments to one or more lesions and is limited to an entire course not to exceed five fractions.
Service type: Radiation therapy — stereotactic body radiation therapy (SBRT) delivery, per fraction.
Typical site of service: Hospital outpatient department or free-standing radiation oncology center.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of metastatic non-small cell lung cancer is referred for stereotactic body radiation therapy (SBRT) to a 2.5 cm peripheral lung lesion identified on recent CT and PET imaging. The multidisciplinary tumor board determined the lesion is appropriate for SBRT due to limited disease burden and prior intolerance to systemic therapy. The radiation oncology workflow includes evaluation and simulation with immobilization, CT simulation with 4D motion assessment, fusion of diagnostic PET/CT for target delineation, treatment planning with high-dose per fraction conformal beams or volumetric-modulated arc therapy, and image-guided delivery.
On each treatment day, pre-treatment image guidance (cone-beam CT or fan-beam CT) is obtained and compared to planning images. Real-time positron emissions-based delivery adjustments are available and used when PET-guided tracking detects intrafraction target motion or metabolic shifts, with automatic gating or couch/shifting as needed. This HCPCS Level II code C9795 represents the per-fraction delivery of SBRT with image guidance and real-time PET-based delivery adjustments for up to five fractions. Typical staff involved include a radiation oncologist, medical physicist, dosimetrist, radiation therapists, and nursing. Typical sites of service are hospital outpatient departments, freestanding radiation oncology centers, and tertiary care cancer centers. Typical clinical scenarios include primary early-stage lung tumors, isolated liver metastases, spinal oligometastases, or other limited-volume metastatic lesions where highly conformal, image-guided, high-dose-per-fraction radiotherapy is indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|